Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd
Most people who received a third dose of Pfizer Inc's COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel.
Thirty-one percent reported some side effect, the most common being soreness at the injection site.
About 0.4 per cent said they suffered from difficulty breathing, and 1 per cent said they sought medical treatment due to one or more side effect.
Ran Balicer, Clalit's chief innovation officer, said that even though the results are "initial and self-reported," they allow a comparison of side effects with the second dose, and "it turns out that in most cases they are similar or less in the booster."
